MIM
ORGO icon

Monashee Investment Management’s Organogenesis Holdings ORGO Stock Holding History

Monashee Investment Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-115,818
Closed -$557K – 81
2019
Q4 		$557K Buy
115,818
+98,716
+577% +$626K 0.52% 49
2019
Q3 		$112K Buy
+17,102
New +$95.2K 0.05% 98
2017
Q3 		– Sell
-200,000
Closed -$1.97M – 110
2017
Q2 		$1.97M Buy
+200,000
New +$1.97M 0.83% 34

Other funds holding ORGO

PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HSA
Hussman Strategic Advisors Ellicott City, Maryland $463M AUM 16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Monashee Investment Management's ORGO Position: Q1 2020 in Review

Monashee Investment Management sold out of Organogenesis Holdings (ORGO) in Q1 2020, closing a stake of 115,818 shares — an estimated $557K sold.

Monashee Investment Management first reported a position in ORGO in Q2 2017 and held it in 3 quarters. The position peaked at $1.97M in Q2 2017. 52 funds tracked by Wall St. Rank hold ORGO as of Q1 2020.

  • Monashee Investment Management reported no remaining Organogenesis Holdings position as of Q1 2020 after selling out during the quarter.
  • Monashee Investment Management sold 115,818 Organogenesis Holdings shares in Q1 2020, an estimated $557K.
  • Monashee Investment Management first reported a position in Organogenesis Holdings in Q2 2017 and held it in 3 quarters.
  • Monashee Investment Management's Organogenesis Holdings position peaked at $1.97M in Q2 2017.
  • 52 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2020.

Based on Monashee Investment Management's 13F filing for Q1 2020, filed 13 May 2020.